Advice
In April 2024, insulin detemir (Levemir®) for injection via the InnoLet® device was discontinued.
Medicine details
- Medicine name:
- insulin detemir, 100 U/ml solution for injection via InnoLet device (Levemir in InnoLet)
- SMC ID:
- 393/07
- Indication:
diabetes mellitus
- Pharmaceutical company
- Novo Nordisk Ltd
- BNF chapter
- Endocrine system
- Submission type
- Abbreviated
- Status
- Withdrawn
- Date advice published
- 13 August 2007
Additional notes
In April 2024, insulin detemir (Levemir®) for injection via the InnoLet® device was discontinued.